Trust Co. of Toledo NA OH Purchases New Position in Solventum Corporation $SOLV

Trust Co. of Toledo NA OH purchased a new stake in Solventum Corporation (NYSE:SOLV) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 1,826 shares of the company’s stock, valued at approximately $138,000.

A number of other large investors have also recently modified their holdings of SOLV. Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in shares of Solventum by 0.7% during the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 19,778 shares of the company’s stock valued at $1,500,000 after buying an additional 140 shares during the last quarter. Tradition Wealth Management LLC lifted its position in shares of Solventum by 1.6% during the first quarter. Tradition Wealth Management LLC now owns 8,830 shares of the company’s stock valued at $671,000 after buying an additional 143 shares during the last quarter. Perigon Wealth Management LLC lifted its position in Solventum by 3.8% during the first quarter. Perigon Wealth Management LLC now owns 4,352 shares of the company’s stock valued at $331,000 after acquiring an additional 159 shares during the last quarter. SouthState Corp lifted its position in Solventum by 31.9% during the first quarter. SouthState Corp now owns 699 shares of the company’s stock valued at $53,000 after acquiring an additional 169 shares during the last quarter. Finally, HB Wealth Management LLC lifted its position in Solventum by 5.6% during the second quarter. HB Wealth Management LLC now owns 3,463 shares of the company’s stock valued at $263,000 after acquiring an additional 185 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on SOLV shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Solventum in a report on Wednesday, October 8th. Piper Sandler reiterated an “overweight” rating and set a $94.00 price objective (up previously from $87.00) on shares of Solventum in a report on Friday, August 8th. Morgan Stanley upgraded Solventum from an “equal weight” rating to an “overweight” rating and increased their price target for the company from $80.00 to $103.00 in a research note on Tuesday, July 15th. Wall Street Zen cut Solventum from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, September 9th. Finally, Jefferies Financial Group began coverage on shares of Solventum in a research report on Thursday, September 11th. They issued a “hold” rating and a $80.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Solventum has a consensus rating of “Hold” and a consensus price target of $84.89.

Solventum Trading Down 1.8%

Shares of NYSE:SOLV opened at $70.53 on Monday. The company has a quick ratio of 0.86, a current ratio of 1.22 and a debt-to-equity ratio of 2.14. Solventum Corporation has a 52-week low of $60.70 and a 52-week high of $85.92. The business has a 50-day moving average price of $72.75 and a 200-day moving average price of $72.08. The stock has a market cap of $12.23 billion, a price-to-earnings ratio of 32.65, a PEG ratio of 2.87 and a beta of 0.50.

Solventum (NYSE:SOLV) last released its quarterly earnings data on Thursday, August 7th. The company reported $1.69 EPS for the quarter, beating the consensus estimate of $1.45 by $0.24. The business had revenue of $2.16 billion for the quarter, compared to the consensus estimate of $2.12 billion. Solventum had a net margin of 4.52% and a return on equity of 29.93%. The business’s revenue for the quarter was up 3.8% on a year-over-year basis. During the same period in the prior year, the firm earned $1.56 EPS. Solventum has set its FY 2025 guidance at 5.800-5.950 EPS. Equities analysts predict that Solventum Corporation will post 6.58 EPS for the current year.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.